Achaogen Stock

Achaogen EV/EBIT

Delisted

The EV/EBIT (Enterprise Value to EBIT) of Achaogen (AKAOQ) as of Aug 13, 2026 is -0.01. In the previous year, EV/EBIT (Enterprise Value to EBIT) was -0.01 — a change of -30.53% (higher).

EV/EBIT

-0.01

YoY

-30.53%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Achaogen is 2026 -0.01 . EV/EBIT (Enterprise Value to EBIT) of Achaogen was 2025 -0.01 . It decreases by -30.53% higher compared to the previous year.

The Achaogen EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PRICE-TO-EBIT
Date
PRICE-TO-EBIT
Jan 1, 2013
0.00 base
Jan 1, 2014
0.00 base
Jan 1, 2015
0.00 base
Jan 1, 2016
0.00 base
Jan 1, 2017
0.00 base
Jan 1, 2018
0.00 base
Jan 1, 2019 (e)
0.00 base
Jan 1, 2020 (e)
0.00 base
YEARPRICE-TO-EBIT
2020 est -
2019 est -
2018 -
2017 -
2016 -
2015 -
2014 -
2013 -
2012 -
2011 -
Access this data via the Eulerpool API
Get Free API Key

Achaogen Stock analysis

What does Achaogen do? Achaogen Inc is an innovative biotechnology company specializing in the development of antibiotics for the treatment of life-threatening infectious diseases. The company's business model is based on research and development of new antibiotics, aiming to improve medical care for patients with infections. Achaogen was founded in 2002 by a team of researchers and professionals in the biotechnology industry and has developed several products for the treatment of diseases such as pneumonia, urinary tract infections, and bloodstream infections. The company's main divisions include Plazomicin, Zemdri, and C-Scape, which are antibiotics targeting different types of infections. Achaogen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Achaogen stock

EV/EBIT (Enterprise Value to EBIT) of Achaogen is -0.01 in 2026.

EV/EBIT (Enterprise Value to EBIT) of Achaogen changed from -0.01 to -0.01, representing a -30.53% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) Achaogen since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s Achaogen with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API
Get Free API Key

Valuation — Achaogen

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueEV/EBITForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Achaogen